RCB1229

Short the pop

Short
RCB1229 Updated   
NASDAQ:EYEG   AB Corporate Bond ETF
Even with the fear of biotech companies flying high when they have successful trials, I like the short today. This is a preliminary study that provided very positive news, however the long term price deterioration of the stock points to a pullback and setbacks. This is speculative, thus good luck trading! Great open if you were long!
Trade active:
Unfortunately my broker couldnt provide a locate... hopefully money was made elsewhere
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.